Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 468 to 517 of 3228 in total
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.16666666666667\textwidth} \def\wcB{0.16666666666667\textwidth} \def\wcC{0.16666666666667\textwidth} \def\wcD{0.16666666666667\textwidth} \def\wcE{0.16666666666667\textwidth} \begin{longtable}{|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 468\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent chromatin assembly factor 1 subunit c (caf-1 subunit c) (chromatin assembly factor i p48 subunit) (caf-i 48 kda subunit) (caf-ip48) (retinoblastoma binding protein p48) (retinoblastoma-binding protein 4) (rbbp-4) (msi1 protein homolog). [source:swissprot;acc:q09028]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4869.15\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5578.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.14558\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 469\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent proliferating-cell nucleolar antigen p120 (proliferation-associated nucleolar protein p120). [source:swissprot;acc:p46087]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 3831.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4388.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.14554\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 470\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent block of proliferation 1. [source:swissprot;acc:q14137]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 3796.24\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4348.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.1455\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 471\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent mitogen-activated protein kinase 12 (ec 2.7.1.37) (extracellular signal-regulated kinase 6) (erk-6) (erk5) (stress-activated protein kinase-3) (mitogen-activated protein kinase p38 gamma) (map kinase p38 gamma). [source:swissprot;acc:p53778]\vspace{3pt}}&\multirow{15}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 9649.61\vspace{3pt}}}&\multirow{15}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 11053.5\vspace{3pt}}}&\multirow{15}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.14549\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 472\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sphingosine kinase 1 (ec 2.7.1.-) (sk 1) (spk 1). [source:swissprot;acc:q9nya1]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 473\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent udp-n-acetylglucosamine--dolichyl-phosphate n- acetylglucosaminephosphotransferase (ec 2.7.8.15) (gpt) (g1pt) (n-acetylglucosamine-1-phosphate transferase) (glcnac-1-p transferase). [source:swissprot;acc:q9h3h5]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 474\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent rho-gtpase-activating protein 7 (rho-type gtpase-activating protein 7) (deleted in liver cancer 1 protein) (dlc-1) (hp protein) (star-related lipid transfer protein 12) (stard12) (start domain-containing protein 12). [source:swissprot;acc:q96qb1]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 475\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent map kinase-activated protein kinase 2 (ec 2.7.1.-) (mapk-activated protein kinase 2) (mapkap kinase 2) (mapkapk-2). [source:swissprot;acc:p49137]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 476\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent neuronal acetylcholine receptor protein, alpha-6 chain precursor. [source:swissprot;acc:q15825]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 477\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nitrogen fixation cluster-like. [source:refseq;acc:nm\_014301]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 478\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent star-related lipid transfer protein 13 (stard13) (start domain- containing protein 13) (46h23.2). [source:swissprot;acc:q9y3m8]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 479\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent star-related lipid transfer protein 8 (stard8) (start domain- containing protein 8). [source:swissprot;acc:q92502]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 480\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent neuronal acetylcholine receptor protein, alpha-2 chain precursor. [source:swissprot;acc:q15822]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 481\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent mitogen-activated protein kinase-activated protein kinase 3; mapkap kinase 3. [source:refseq;acc:nm\_004635]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 482\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent mitogen-activated protein kinase 14 (ec 2.7.1.37) (mitogen-activated protein kinase p38alpha) (map kinase p38alpha) (cytokine suppressive anti-inflammatory drug binding protein) (csaid binding protein) (csbp) (max-interacting protein 2) (map kinase mxi2) (sapk2a). [source:swissprot;acc:q16539]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 483\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent neuronal acetylcholine receptor protein, alpha-4 chain precursor. [source:swissprot;acc:p43681]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 484\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent neuronal acetylcholine receptor protein, alpha-3 chain precursor. [source:swissprot;acc:p32297]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 485\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sphingosine kinase 2 (ec 2.7.1.-) (sk 2) (spk 2). [source:swissprot;acc:q9nra0]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 486\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent stem cell growth factor; lymphocyte secreted c-type lectin; lymphocyte secreted c-type lectin. [source:refseq;acc:nm\_002975]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 10908.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 12491.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.14513\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 487\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent pyrroline 5-carboxylate reductase isoform. [source:refseq;acc:nm\_013328]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5277.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6042.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.14505\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 488\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent c-type lectin superfamily member 1 precursor (cartilage-derived c-type lectin). [source:swissprot;acc:o75596]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 10872.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 12447\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.14483\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 489\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent pyrroline-5-carboxylate reductase (ec 1.5.1.2) (p5cr) (p5c reductase). [source:swissprot;acc:p32322]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5281.11\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6044.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.14457\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 490\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent protein phosphatase 1, regulatory (inhibitor) subunit 13b; apoptosis-stimulating protein of p53, 1. [source:refseq;acc:nm\_015316]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 15274.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 13346.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.14445\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 491\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent neuron navigator 2 isoform l; retinoic acid inducible in neuroblastoma; pore membrane and/or filament interacting like protein 2; helicase helad1. [source:refseq;acc:nm\_145117]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5980.15\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6843.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.14437\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 492\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent neuron navigator 1; neuron navigator-1; pore membrane and/or filament interacting like protein 3. [source:refseq;acc:nm\_020443]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5979.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6842.76\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.14429\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 493\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent neuron navigator 3; pore membrane and/or filament interacting like protein 1; steerin 3. [source:refseq;acc:nm\_014903]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5979.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6842.78\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 494\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent e2a-pbx1-associated protein; putative 47 kda protein. [source:refseq;acc:nm\_020140]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5979.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6842.72\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.14428\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 495\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent tetranectin precursor (tn) (plasminogen-kringle 4 binding protein). [source:swissprot;acc:p05452]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 10804.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 12363.6\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 496\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nostrin. [source:refseq;acc:nm\_052946]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 4682.87\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 4093.05\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.1441\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 497\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent eap30 subunit of ell complex. [source:refseq;acc:nm\_007241]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 498\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent liv-1 protein, estrogen regulated. [source:refseq;acc:nm\_012319]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 499\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent glutamate decarboxylase, 65 kda isoform (ec 4.1.1.15) (gad-65) (65 kda glutamic acid decarboxylase). [source:swissprot;acc:q05329]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 500\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent gamma-soluble nsf attachment protein (snap-gamma) (n-ethylmaleimide- sensitive factor attachment protein, gamma). [source:swissprot;acc:q99747]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 501\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent glutamate decarboxylase, 67 kda isoform (ec 4.1.1.15) (gad-67) (67 kda glutamic acid decarboxylase). [source:swissprot;acc:q99259]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 502\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ribonucleoside-diphosphate reductase m1 chain (ec 1.17.4.1) (ribonucleotide reductase large chain). [source:swissprot;acc:p23921]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6913.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7907.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.1437\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 503\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent tumor suppressor p53-binding protein 2 (p53-binding protein 2) (53bp2) (bcl2-binding protein) (bbp). [source:swissprot;acc:q13625]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 15182.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 13277.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.14344\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 504\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent enoyl-coa hydratase, mitochondrial precursor (ec 4.2.1.17) (short chain enoyl-coa hydratase) (sceh) (enoyl-coa hydratase 1). [source:swissprot;acc:p30084]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 10067.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 11511\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.14334\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 505\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent signal transduction protein cbl-b (sh3-binding protein cbl-b). [source:swissprot;acc:q13191]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6856.71\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7838.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.14316\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 506\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent eukaryotic translation initiation factor 6 (eif-6) (b4 integrin interactor) (cab) (p27(bbp)) (b(2)gcn homolog). [source:swissprot;acc:p56537]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 3893.85\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4450.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.14308\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 507\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cbl e3 ubiquitin protein ligase (ec 6.3.2.-) (signal transduction protein cbl) (proto-oncogene c-cbl). [source:swissprot;acc:p22681]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6875.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7858.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.14302\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 508\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1-acyl-sn-glycerol-3-phosphate acyltransferase beta (ec 2.3.1.51) (1- agp acyltransferase 2) (1-agpat 2) (lysophosphatidic acid acyltransferase-beta) (lpaat-beta) (1-acylglycerol-3-phosphate o- acyltransferase 2). [source:swissprot;acc:o15120]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7556.75\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 8636.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.14293\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 509\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (ec 2.3.1.51) (1- agp acyltransferase 1) (1-agpat 1) (lysophosphatidic acid acyltransferase-alpha) (lpaat-alpha) (1-acylglycerol-3-phosphate o- acyltransferase 1) (g15 protein). [source:swissprot;acc:q99943]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7551.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 8630.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.14278\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 510\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent growth factor receptor-bound protein 2 (grb2 adapter protein) (sh2/sh3 adapter grb2) (ash protein). [source:swissprot;acc:p29354]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5975.11\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6826.24\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.14245\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 511\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent serine/threonine-protein kinase nek2 (ec 2.7.1.37) (nima-related protein kinase 2) (nima-like protein kinase 1) (hspk 21). [source:swissprot;acc:p51955]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 512\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent small glutamine rich protein with tetratricopeptide repeats 2. [source:refseq;acc:nm\_019072]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 10807.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 12338.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.14167\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 513\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1-acyl-sn-glycerol-3-phosphate acyltransferase gamma (ec 2.3.1.51) (1- agp acyltransferase 3) (1-agpat 3) (lysophosphatidic acid acyltransferase-gamma) (lpaat-gamma) (1-acylglycerol-3-phosphate o- acyltransferase 3). [source:swissprot;acc:q9nrz7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7485.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 8543.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.14143\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 514\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 1-acyl-sn-glycerol-3-phosphate acyltransferase delta (ec 2.3.1.51) (1- agp acyltransferase 4) (1-agpat 4) (lysophosphatidic acid acyltransferase-delta) (lpaat-delta) (1-acylglycerol-3-phosphate o- acyltransferase 4). [source:swissprot;acc:q9nrz5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7477\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 8532.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.1411\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 515\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent transcription factor dp-1 (e2f dimerization partner 1) (drtf1- polypeptide-1) (drtf1). [source:swissprot;acc:q14186]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 3890.53\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4439.07\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.14099\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 516\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent n-acetylgalactosamine kinase (ec 2.7.1.-) (galnac kinase) (galactokinase 2). [source:swissprot;acc:q01415]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 4910.6\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5600.61\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.14051\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 517\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent galactose-1-phosphate uridylyltransferase (ec 2.7.7.12) (gal-1-p uridylyltransferase) (udp-glucose--hexose-1-phosphate uridylyltransferase). [source:swissprot;acc:p07902]\vspace{3pt}}&&&\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/